- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00769054
Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study
July 8, 2010 updated by: Hvidovre University Hospital
Lokal Infiltrations Analgesi Med Ropivakain 1 % Versus Placebo VED Vaginale Descensusoperationer: ET Prospektivt Randomiseret, Dobbeltblindet, Placebo- Kontrolleret Studie
The purpose of this study is to compare systematic local infiltration with ropivacaine or placebo in patients undergoing repair of posterior vaginal wall prolapse.
The hypothesis is that LIA technique is opioid-sparing and a better postoperative treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
48
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hvidovre
-
Copenhagen, Hvidovre, Denmark, 2650
- Hvidovre University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- eligible for elective repair of posterior vaginal wall prolapse
- able to speak and understand Danish
- able to give informed consent
Exclusion Criteria:
- alcohol or medical abuse
- allergies to local anesthetics
- age < 18 yrs.
- intolerance to opioids
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1
Local Infiltration with Ropivacaine
|
Local Infiltration Analgesia with 1 % Ropivacaine
|
Placebo Comparator: 2
Local Infiltration with Placebo
|
Local Infiltration with NaCl
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Postoperative Pain during rest, coughing and ambulation
Time Frame: ½, 1, 2, 4, 8, 12 and 24 h postoperatively
|
½, 1, 2, 4, 8, 12 and 24 h postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Postoperative Nausea and Vomitus
Time Frame: ½, 1, 2, 4, 8, 12 and 24 h postoperatively
|
½, 1, 2, 4, 8, 12 and 24 h postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Billy B Kristensen, MD, Hvidovre University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
October 1, 2009
Study Completion (Actual)
October 1, 2009
Study Registration Dates
First Submitted
October 7, 2008
First Submitted That Met QC Criteria
October 7, 2008
First Posted (Estimate)
October 8, 2008
Study Record Updates
Last Update Posted (Estimate)
July 9, 2010
Last Update Submitted That Met QC Criteria
July 8, 2010
Last Verified
October 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-C-2008-035
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Prolapse
-
The Methodist Hospital Research InstituteUnknownVaginal Vault Prolapse | Post-Hysterectomy Vaginal Vault Prolapse | Prolapse, VaginalUnited States
-
Ain Shams UniversityCompletedUterovaginal and Vaginal Vault ProlapseEgypt
-
Kaiser PermanenteMassachusetts General HospitalUnknownProlapse of Vaginal Vault After HysterectomyUnited States
-
University of SalfordUnknownPelvic Organ Prolapse | Cystocele | Uterine Prolapse | Rectocele | Anterior Wall; Prolapse, Vaginal | Posterior Wall; Prolapse, Vaginal | Vault Prolapse, VaginalUnited Kingdom
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
National Taiwan University HospitalCompletedVault Prolapse, Vaginal
-
Centre Hospitalier Universitaire de NīmesCompletedVaginal ProlapseFrance
-
Azienda Ospedaliera Cardinale G. PanicoCompletedPelvic Organ Prolapse | Posterior Vaginal Wall ProlapseItaly
-
Tampere UniversityCompleted
-
Lyra Medical Ltd.CompletedAnterior Vaginal Wall Prolapse | Vaginal Apex/Uterine ProlapseHungary, Israel
Clinical Trials on Ropivacaine
-
Ziekenhuis Oost-LimburgNot yet recruitingAnesthesia | Hallux Valgus
-
University Health Network, TorontoUnknownPIB Versus CI Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle SurgeryPain, PostoperativeCanada
-
Northwestern UniversityCompletedPostoperative PainUnited States
-
Hospices Civils de LyonCompleted
-
Pusan National University HospitalCompletedHemodynamics | Epidural Anesthesia | Ropivacaine ConcentrationKorea, Republic of
-
Northwestern UniversityCompletedObesity | Postoperative Pain | PregnancyUnited States
-
Universiteit AntwerpenCompleted
-
San Gerardo HospitalIRCCS Policlinico S. Matteo; University of Milano Bicocca; Azienda L'ULSS 15... and other collaboratorsCompletedLaparoscopic CholecystectomyItaly
-
China Medical University, ChinaCompleted
-
China Medical University, ChinaWithdrawn